5-n-Heptadecylresorcinol (C17:0)

ID145
Name5-n-Heptadecylresorcinol (C17:0)
Synonyms
StructureThumb
Description
GroupPolyphenols
Sub-groupAlkylresorcinols
Exposure sourceDiet
Use
CAS number41442-57-3
PubChem ID181700
ChEBI ID
FooDB IDFDB017915
HMDB IDHMDB38530

Biomarker measurements

Biomarker concentration values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
104210471AllAdults from the university campus area in UppsalaSwedenSEbaselinePlasma, fastingGC-MS5-n-Heptadecylresorcinol (C17:0)515.04.07.0nmol/L5.0 nmol/LCrudeAndersson 2011
104910541AllAdults from the university campus area in UppsalaSwedenSE3 monthsPlasma, fastingGC-MS5-n-Heptadecylresorcinol (C17:0)516.04.07.0nmol/L6.0 nmol/LCrudeAndersson 2011
344934551All [by diet]Postmenopausal and premenopausal women living in the Helsinki areaFinlandFIPlasma, fastingGC-MS5-n-Heptadecylresorcinol (C17:0)5610.55.7nmol/L10.5 nmol/LCrudeAubertin-Leheudre 2008
346334691VegetariansPostmenopausal and premenopausal women living in the Helsinki areaFinlandFIPlasma, fastingGC-MS5-n-Heptadecylresorcinol (C17:0)209.24.3nmol/L9.2 nmol/LCrudeAubertin-Leheudre 2008
347734831OmnivoresPostmenopausal and premenopausal women living in the Helsinki areaFinlandFIPlasma, fastingGC-MS5-n-Heptadecylresorcinol (C17:0)3610.96.1nmol/L10.9 nmol/LCrudeAubertin-Leheudre 2008
18549185541AllParticipants without a history of heart diseaseGermanyDEEPIC-Potsdam (European Prospective Investigation into Cancer and Nutrition)baselinePlasma, fastingGC-MS5-n-Heptadecylresorcinol (C17:0)1005.34.446.34nmol/L5.3 nmol/LCrudeMontonen 2010
18555185601AllParticipants without a history of heart diseaseGermanyDEEPIC-Potsdam (European Prospective Investigation into Cancer and Nutrition)4 monthsPlasma, fastingGC-MS5-n-Heptadecylresorcinol (C17:0)1005.054.26.07nmol/L5.1 nmol/LCrudeMontonen 2010
19073190781AllResidents of the Vasterbotten regionSwedenSEVIP cohort (Vasterbotten Intervention Project)baselinePlasma, fastingGC-MS5-n-Heptadecylresorcinol (C17:0)736.04.97.3nmol/L6.0 nmol/LCrudeLandberg 2013

Intake values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionIntake toolIntake food coverageIntake time coverageIntake assessmentCompoundCompound detailSupplement intakes included?Measurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
101710221AllAdults from the university campus area in UppsalaSwedenSEbaselineSwedish National Food AdministrationWeighed Dietary record (3-day)5-n-Heptadecylresorcinol (C17:0)726.06.0mg/day6.0 mg/dayCrudeAndersson 2011
103510401AllAdults from the university campus area in UppsalaSwedenSE3 monthsSwedish National Food AdministrationWeighed Dietary record (3-day)5-n-Heptadecylresorcinol (C17:0)726.06.0mg/day6.0 mg/dayCrudeAndersson 2011

Correlation values

Reproducibility values

IDMst. IDSubject groupPopulationCountryCountry codeCohortTime definitionBiological specimenExperimental methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication
41067AllAdults from the university campus area in UppsalaSwedenSEbaseline; 3 monthsPlasma, fastingGC-MS5-n-Heptadecylresorcinol (C17:0)nmol/L510.530.340.71Andersson 2011
24118543AllParticipants without a history of heart diseaseGermanyDEEPIC-Potsdam (European Prospective Investigation into Cancer and Nutrition)baseline; 4 monthsPlasma, fastingGC-MS5-n-Heptadecylresorcinol (C17:0)nmol/L1000.350.160.51Montonen 2010
60119065AllResidents of the Vasterbotten regionSwedenSEVIP cohort (Vasterbotten Intervention Project)baseline; 2 yearsPlasma, fastingGC-MS5-n-Heptadecylresorcinol (C17:0)nmol/L730.640.490.76Landberg 2013